Biotech Stock News: A Look At The Best Prospects For The Week
Tax inversion deals are no longer looking so attractive given the notice issued by the U.S. Department of Treasury in September. In fact, AbbVie (ABBV) has dropped its plans to acquire Shire and will be paying a break-up fee. Meanwhile, Amgen (AMGN) is being urged to consider splitting into two companies which would create more value. AbbVie called off its plans to acquire Shire – … Continue reading Biotech Stock News: A Look At The Best Prospects For The Week
